For a patient receiving treatment for infective endocarditis, what is the primary reason for conducting blood cultures? A. To detect electrolyte imbalances.

Choice A rationale Electrolyte imbalances, such as variations in potassium (3.5 to 5.0 mEq/L) or sodium (135 to 145 mEq/L), are typically identified through a basic metabolic panel rather than blood cultures. Cultures are designed specifically to provide a nutrient-rich environment for the proliferation of aerobic and anaerobic microorganisms. Electrolyte shifts may occur during systemic inflammatory responses, but they do not serve as the primary diagnostic focus when assessing the presence of endocardial infections. Choice B rationale Hydration status is usually evaluated by monitoring clinical markers such as skin turgor, mucous membrane moisture, urine output, and laboratory values like blood urea nitrogen (7 to 20 mg/dL) and urine specific gravity (1.005 to 1.030). Blood cultures are not used to measure fluid volume or plasma osmolality. While a patient with a fever may experience insensible fluid loss, the specific utility of a culture remains limited to the detection of viable circulating pathogens. Choice C rationale Assessing the immune system response generally involves analyzing a complete blood count to determine the white blood cell count (5,000 to 10,000/mm) and the differential, including neutrophils and lymphocytes. While the presence of an infection triggers an immune response, blood cultures are intended to isolate the external invader rather than quantify the host's internal defensive cells. Therefore, cultures provide information about the microbial load and identity rather than the functional capacity of the immune system. Choice D rationale In infective endocarditis, microbes colonize the heart valves, often leading to continuous bacteremia. Blood cultures are the gold standard for identifying the specific bacterial or fungal species responsible for the vegetative growth. Identifying the pathogen allows for antimicrobial susceptibility testing, which ensures the selection of the most effective antibiotic. This targeted approach is essential for eradicating the infection, preventing valvular destruction, and reducing the risk of embolic events or systemic sepsis in the patient.